Fmr LLC Tekla Life Sciences Investors Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Fmr LLC holds 2 shares of HQL stock, worth $29. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 1
100.0%
Holding current value
$29
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HQL
# of Institutions
78Shares Held
9.01MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$50.2 Million0.82% of portfolio
-
Morgan Stanley New York, NY490KShares$7.18 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA419KShares$6.14 Million0.53% of portfolio
-
Karpus Management, Inc. Pittsford, NY404KShares$5.92 Million0.18% of portfolio
-
Needham Investment Management LLC New York, NY342KShares$5.01 Million0.42% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...